Recon Regulatory Top Stories Lipogems Announces Last Patient Enrolled in the U.S. FDA IDE Arise Study for the Treatment of Knee Osteoarthritis byTim AllenApril 10, 2024
Recon Regulatory Top Stories Lipogems Announces First Patient Enrolled in the Second U.S. FDA IDE Study for the Treatment of Knee Osteoarthritis byTim AllenApril 8, 2024
Biologics Regulatory U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA byJosh SandbergOctober 4, 2023
Extremities Top Stories Paragon 28®, Inc. Receives FDA Approval for IDE Feasibility Study of Its SMART Total Talus™ System for use in Conjunction with the APEX 3D™ Total Ankle Replacement System byJosh SandbergSeptember 11, 2023
Spine Synergy Spine Solutions Announces First Patient Enrolled in the Synergy Disc® 2-Level IDE Trial byJosh SandbergJune 29, 2023
Spine Top Stories Synergy Spine Solutions Completes Enrollment of 1-Level IDE Trial byJosh SandbergJune 5, 2023
Regulatory Spine Top Stories AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial byJosh SandbergAugust 9, 2022
Biologics Extremities Regulatory Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis byChris StewartJune 10, 2022
